nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Brazil sustains HIV response during the COVID-19 pandemic
|
Pereira, Gerson F Mendes |
|
|
8 |
2 |
p. e65 |
artikel |
2 |
Do not repeat mistakes from HIV in COVID-19 response
|
The Lancet HIV, |
|
|
8 |
2 |
p. e59 |
artikel |
3 |
Educating Russia about HIV/AIDS
|
Holt, Ed |
|
|
8 |
2 |
p. e66 |
artikel |
4 |
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study
|
Smit, Colette |
|
|
8 |
2 |
p. e96-e105 |
artikel |
5 |
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial
|
Korthuis, P Todd |
|
|
8 |
2 |
p. e67-e76 |
artikel |
6 |
Imperfect progress: treatment options for opioid dependence
|
Sabin, Keith M |
|
|
8 |
2 |
p. e60-e61 |
artikel |
7 |
Micro-elimination of HIV and HCV co-infection
|
Dusheiko, Geoff |
|
|
8 |
2 |
p. e61-e62 |
artikel |
8 |
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study
|
Nel, Annalene |
|
|
8 |
2 |
p. e77-e86 |
artikel |
9 |
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study
|
Baeten, Jared M |
|
|
8 |
2 |
p. e87-e95 |
artikel |
10 |
Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention
|
Rowan, Sarah E |
|
|
8 |
2 |
p. e114-e120 |
artikel |
11 |
Stigma reduction: an essential ingredient to ending AIDS by 2030
|
Nyblade, Laura |
|
|
8 |
2 |
p. e106-e113 |
artikel |
12 |
Universal health care needed to end HIV epidemic in the USA
|
Goedel, William C |
|
|
8 |
2 |
p. e63-e64 |
artikel |